Columbia Research Enhanced Small Cap ETF (RESM)

The Columbia Research Enhanced Small Cap ETF (ticker RESM) is an actively managed fund holding small-sized American public companies selected through rigorous fundamental research. It is the evolution of Columbia’s equity practice, which has traced its roots back decades through multiple iterations and acquisitions, refining its approach to finding underfollowed companies with genuine growth ahead.

From research partnerships to the modern active ETF

Columbia’s equity research operation has deep institutional history. The firm’s predecessors included equity boutiques and research shops that built their reputations by studying small companies when few institutions paid attention. Over the decades, through acquisitions and mergers, Columbia accumulated teams of sector specialists and company analysts who developed expertise in identifying small cap winners early.

The shift to the ETF structure is relatively recent. For most of its history, Columbia managed equity strategies through traditional mutual funds and separately managed accounts for wealthy investors. As the ETF market grew and passive indexing gained market share, Columbia developed actively managed ETFs as a way to offer its research-driven equity picking with modern trading and tax efficiency. RESM represents this evolution—taking the research philosophy honed over decades and packaging it in a vehicle that allows daily trading and intraday liquidity.

The fund itself launched as part of a suite of active ETFs designed to serve investors who believe in active management’s potential but want the flexibility and cost structure of an ETF. It inherited Columbia’s institutional commitment to fundamental research—deep-dive analysis rather than algorithmic screening or trend-following.

The small cap research advantage

Small cap investing is where active management theoretically has the greatest edge. Large-cap stocks like Apple, Microsoft, and Coca-Cola are covered by dozens of Wall Street analysts; new information spreads rapidly; prices reflect the consensus quickly. Small cap stocks, by contrast, have minimal analyst coverage. Many small companies have no coverage at all—no sell-side research, no investor relations, little institutional ownership. This creates genuine information gaps.

Columbia’s research team digs into that gap. Analysts visit small companies’ factories, talk with customers and competitors, model long-term earnings power, and assess management quality. They hunt for companies with sustainable competitive advantages trading below intrinsic value, or companies at a inflection point where growth is about to accelerate. Finding a company in the Russell 2000 that has been mispriced by the market can generate outsized returns before the broader market catches on.

The small cap segment is also less efficient than large cap, meaning pricing anomalies linger longer. A small company trading at an unsustainably low valuation relative to its earnings growth might stay cheap for several quarters or longer, giving a patient investor time to accumulate a position before the market reprices it.

Active vs. passive in small cap: the historical debate

History presents a mixed record. In some decades, active small cap managers outperformed their passive benchmarks consistently; in others, they lagged. The 1990s and 2000s saw many active small cap funds beat index funds; the past ten years have been tougher. Low-cost passive index funds have captured increasing market share, attracting flows and making it harder for active managers to find mispriced stocks.

RESM operates with this headwind: it must overcome its 0.60–0.75% annual fee by outperforming the Russell 2000 by at least that much just to break even relative to a passive small cap index fund. Over long periods, the odds are against it, though in any given five- or ten-year window, strong research can deliver. Columbia’s track record across its equity capabilities is relevant; if the firm has demonstrated skill in mid cap research (as with REMC), that skill might transfer to small cap.

Building the fund: positioning and concentration

RESM’s portfolio is built by Columbia’s small cap specialists across multiple sectors. The team maintains sector discipline, avoiding overconcentration in any single industry while pursuing its highest-conviction ideas. Early-stage healthcare companies, software businesses with recurring revenue, niche manufacturing firms with strong margins—these kinds of opportunities populate the portfolio.

The fund typically holds 60–120 positions, which provides diversification against individual stock risk while maintaining enough concentration that top ideas can meaningfully drive returns. A position might represent 1–2% of the fund for an core conviction, versus 0.5% for a smaller idea.

This approach requires continuous trading and monitoring. As the portfolio team’s views on companies change, or as stocks move from small cap into mid cap (by market cap), positions are added and trimmed. That turnover creates trading costs and, in taxable accounts, taxable gains. Investors considering RESM should expect to pay those costs in exchange for the active stock-picking process.

Risks: concentration, cyclicality, liquidity

Small cap stocks are more volatile than large cap stocks, and RESM amplifies that volatility through active bets. A single holding that goes wrong—a company that loses a major customer or faces unexpected litigation—can hurt more because it is a larger position in a smaller portfolio. Economic downturns hit small cap companies harder than large ones; if a recession occurs, RESM could easily fall 40–50% while the broad market falls 20–25%.

Small cap stocks also trade with wider bid-ask spreads than large cap stocks, so buying and selling them costs more in implicit trading costs. When RESM needs to raise cash to meet redemptions or rebalance, those costs are borne by remaining shareholders. In market stress, small cap liquidity can dry up entirely.

There is also the active risk of bad bets. Research can be rigorous and still lead the team astray. A company that looks great in an analyst’s models might face unexpected competition, regulatory change, or management missteps that destroy value. RESM investors are betting that Columbia’s research process is better than the average, but that remains an unproven proposition going forward.

How to evaluate RESM before committing

Begin with Columbia’s factsheet and detailed portfolio holdings, looking for companies you can recognize and understand. Are they predominantly profitable, growing businesses, or are many of them unprofitable early-stage companies? The portfolio composition reveals the strategy’s true bent.

Compare RESM’s historical returns against a passive small cap fund (like the Vanguard Small Cap ETF or iShares Core S&P Small Cap ETF) over five, ten, and fifteen years. If RESM has outperformed significantly, that suggests skill. If it has lagged, the active fees have dragged down returns. Remember to adjust for taxes in taxable accounts; a low-turnover passive fund often has a tax advantage that is invisible in pretax return comparisons.

Read the fund’s quarterly commentary and annual report. Columbia’s management explains the investment thesis, recent positions, and market outlook. Strong commentary reveals genuine thinking about the companies in the portfolio; weak commentary suggests the team is going through the motions.

Finally, decide whether you believe that active management can deliver excess returns. If you are skeptical, a simple passive small cap index fund is cheaper and likely just as effective. If you do believe, interview your financial advisor or Columbia directly about the team’s track record and philosophy, and commit only capital you can hold for at least five years.